Showing results (161-170 of 386) with videos related to
Sort By:
Pageof 39
Cancer Immunology Research|June 18, 2016
Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating LymphocytesVishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, et al.Pancreas|August 29, 2018
Characterization of the Neuroendocrine Tumor Immune MicroenvironmentAnnacarolina da Silva, Michaela Bowden, Sui Zhang, et al.Cancer Immunology Research|May 6, 2017
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical OutcomesXinqi Wu, Jingjing Li, Erin M Connolly, et al.Journal for Immunotherapy of Cancer|August 21, 2020
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) serviceOsama Abu-Shawer, Prabhsimranjot Singh, Eric Yenulevich, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation TherapyAndrew Bang, Tyler J Wilhite, Luke R G Pike, et al.Frontiers in Oncology|May 30, 2024
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanomaTamara A Sussman, Mariano Severgnini, Anita Giobbie-Hurder, et al.JCO Oncology Practice|May 14, 2020
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic ColitisShilpa Grover, Alex B Ruan, Padmavathi Srivoleti, et al.Cancer Research|November 3, 2021
SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 AxisSatoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, et al.Journal for Immunotherapy of Cancer|March 10, 2022
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumorsOsama E Rahma, Kevin Tyan, Anita Giobbie-Hurder, et al.European Journal of Cancer (Oxford, England : 1990)|July 28, 2018
Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancerStephen V Liu, D Ross Camidge, Scott N Gettinger, et al.Pageof 39